🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NEW STUDY: Monash Institute of Pharmaceutical Sciences researchers, in collab with Monash Medicine, Nursing and Health Sciences and University College Dublin, have discovered that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts 👇 monash.edu/pharm/about/ne…

Congratulations to the outstanding researchers behind the 10 MIPS-led projects to receive funding through the 2025 Australian Research Council Discovery Projects scheme 👏👇 monash.edu/pharm/about/ne…

Congratulations to the brilliant Prof Rebecca Ritchie who has been named a 2024 ASCEPT Fellow - the highest honour the Society bestows upon its members 🙌👏👇 monash.edu/pharm/about/ne…

Congratulations to Carl Kirkpatrick who has been named a 2024 British Pharmacological Society Fellow. Bravo for the very well-deserved recognition! 👏👏👇 monash.edu/pharm/about/ne…

The Monash Institute of Pharmaceutical Sciences team behind Australia’s first mRNA vaccine have published a study on how the vaccine could tackle COVID ‘immune imprinting’. Published in collab with Doherty Institute 👇 Colin Pouton Harry Al-Wassiti Damian Purcell monash.edu/pharm/about/ne…

Check out Norman Swan & Tegan Taylor discussing new Monash Institute of Pharmaceutical Sciences-led research on addressing COVID immune imprinting Colin Pouton Harry Al-Wassiti Doherty Institute 👇 (starts at 5:18) abc.net.au/listen/program…

Congratulations to the Monash Institute of Pharmaceutical Sciences researchers to be awarded $7.8m (total) funding through the latest NHMRC Ideas Grants scheme 👏👏👇 monash.edu/pharm/about/ne…

Bravo to the Monash Institute of Pharmaceutical Sciences-led team behind an NHMRC Development grant focused on improving life expectancy in people living with pulmonary arterial hypertension (PAH) 🙌👇 monash.edu/pharm/about/ne…

A team from @MonashPharmSci (MIPS) has partnered with Microsoft Research AI for Science to enhance GPCR-related drug discovery. Led by Elva Zhao , Denise Wootten and Patrick M Sexton, the team is aiming to develop an AI model that can predict the clinical impact of receptor

Newly published data in Mol Pharm has further validated the versatility of Glyph, a Monash Institute of Pharmaceutical Sciences invention enabling drugs to be absorbed like dietary fats through the intestinal lymphatic system and transported into circulation 👇 monash.edu/pharm/about/ne…

Liquid gold: The Monash Institute of Pharmaceutical Sciences 'Monash Milk Team’ have demonstrated the power of human milk as a highly effective vehicle for administering certain medicines to infants Ellie Ponsonby-Thomas Ben Boyd 👏👇 monash.edu/news/articles/…

For many men the side effects of prostate cancer treatment are “horrendous” - like sex dysfunction, heart disease and diabetes. This discovery could change that. | Herald Sun heraldsun.com.au/health/conditi…

Join digital health experts to discuss Australia's latest milestones in driving 'The Quintuple Aim': ⚡ patient experience ⚡ population health ⚡ cost-efficiency ⚡ workforce wellbeing ⚡ health equity. Register now: bit.ly/3X8XmeB Zanfina Ademi #digitalhealth #healthcare

Congratulations to our NHMRC Investigator grant recipients who have secured funding to improve treatments for obesity, schizophrenia, cancer and other diseases 👏👇 monash.edu/pharm/about/ne…